We evaluated the effectiveness of intravenous iloprost (IVI) in outpatients with thromboangiitis obliterans (TAO) and lower limb noninvasive transcutaneous monitoring (TCM) at follow-up (FU). Ten consecutive patients with TAO underwent IVI therapy. Transcutaneous oxygen (TcPo2) and carbon dioxide (TcPco2) determination and laser Doppler flowmetry (LDF) were performed before and after IVI at 3, 6, and 12 months of FU. Clinical response was positive in 7 patients, whereas 3 nonresponders underwent a second IVI cycle with 1 showing a late positive clinical response. After 12 months of FU, all patients were alive without amputations. Supine and dependent TcP2 levels significantly improved (P < .005). Hallux LDF values showed significant change with the maximal hyperemic test at 44°C (P < .005). Forefoot maximal hyperemic test at 44°C LDF (P < .005) and improved venous arterial reflex (P < .05) showed statistically significant time evolution. We demonstrated some degree of IVI effectiveness and evaluated TCM in patients with TAO.
MillsJLSr. Buerger’s disease in the 21st century: diagnosis, clinical features, and therapy. Seminars Vasc Surg. 2003;16(3):179–189.
5.
ShionoyaS. Diagnostic criteria of Buerger’s disease. Int J Cardiol. 1998;66 (suppl 1):S243–S245.
6.
OhtaTIshioashiHHosakaMSugimotoI. Clinical and social consequences of Buerger disease. J Vasc Surg. 2004;39(1):176–180.
7.
BornerCHeidrichH. Long-term follow-up of thromboangiitis obliterans. Vasa. 1998;27(2):80–86.
8.
HaragusSStancioiuNSchneiderEVlaicuR. Fever therapy in thromboangiitis obliterans [in Romanian]. Med Interna. 1968;20(12):1489–1496.
9.
ChanderJSinghLLalPJainALalPRamtekeVK. Retroperitoneoscopic lumbar sympathectomy for buerger’s disease: a novel technique. JSLS. 2004;8(3):291–296.
10.
BozkurtAKKoksalCDemirbasMY. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger’s disease. Int Angiol. 2006;25(2):162–168.
11.
DonasKPSchulteSKtenidisKHorschS. The role of epidural spinal cord stimulation in the treatment of Buerger’s disease. J Vasc Surg. 2005;41(5):830–836.
12.
FabregatGVillanuevaVLAsensioJMDe AndresJLopezD. Spinal cord stimulation for the treatment of Buerger disease: a report on 3 cases. Clin J Pain. 2011;27(9):819–823.
13.
SaigawaTKatoKOzawaT. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J. 2004;68(12):1189–1193.
14.
MotukuruVSureshKRVivekanandVRajSGirijaKR. Therapeutic angiogenesis in Buerger’s disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. J Vasc Surg. 2008;48(suppl 6):53S–60S.
15.
SaitoYSasakiKKatsudaY. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger’s disease. Circ J. 2007;71(8):1187–1192.
16.
LazaridesMKGeorgiadisGSPapasTTNikolopoulosES. Diagnostic criteria and treatment of Buerger’s disease: a review. Int J Low Extrem Wounds. 2006;5(2):89–95.
17.
SasajimaTKuboYInabaMGohKAzumaN. Role of infrainguinal bypass in Buerger’s disease: an eighteen-year experience. Eur J Vasc Endovasc Surg. 1997;13(2):186–192.
18.
FiessingerJNSchaferM. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study. Lancet. 1990;335(8689):555–557.
19.
BozkurtAKCengizKArslanC. A stable prostacyclin analogue (iloprost) in the treatment of Buerger’s disease: a prospective analysis of 150 patients. Ann Thorac Cardiovasc Surg. 2013;19(2):120–125.
20.
Oral iloprost in the treatment of thromboangiitis obliterans (Buerger’s disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group. Eur J Vasc Endovasc Surg. 1998;15(4):300–307.
21.
MelilloENutiMButtittaFBalbariniA. Medical therapy in critical lower limb ischemia when immediate revascularization is not feasible [in Italian]. G Ital Cardiol (Rome). 2006;7(5):317–335.
22.
MelilloECatapanoGFerrariMPedrinelliR. Transcutaneous oxygen tension measurement in patients with chronic arterial obstructive disease: reliability and long-term variability of the method. Angiology. 1994;45(6):469–475.
23.
IabichellaMLMelilloEMostiG. A review of microvascular measurements in wound healing. Int J low Extrem Wounds. 2006;5(3):181–199.
24.
MaleckiRZdrojowyKAdamiecR. Thromboangiitis obliterans in the 21st century--a new face of disease. Atherosclerosis. 2009;206(2):328–334.
StoynevaZ. Laser Doppler-recorded venoarteriolar reflex in Raynaud’s phenomenon. Auton Neurosci. 2004;116(1-2):62–68.
27.
MinsonCTBerryLTJoynerMJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol. 2001;91(4):1619–1626.
28.
KelloggDLJrLiuYKosibaIFO’DonnellD. Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol. 1999;86(4):1185–1190.
29.
BrunnerHCockcroftJRDeanfieldJ. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23(2):233–246.
30.
HansellJHenarehLAgewallSNormanM. Non-invasive assessment of endothelial function - relation between vasodilatory responses in skin microcirculation and brachial artery. Clin Physiol Funct Imaging. 2004;24(6):317–322.
31.
KrogstadALElamMKarlssonTWallinBG. Arteriovenous anastomoses and the thermoregulatory shift between cutaneous vasoconstrictor and vasodilator reflexes. J Auton Nerv Syst. 1995;53(2-3):215–222.
32.
SuzukiJMaedaJTakemiyaT. Analysis of microvascular responses in the finger to changes in arm position during cold water stimulation. Jpn J Physiol. 1994;44(2):181–191.
